Abiopharma

🔍 MELTZER LESLIE (Executive)

Company: Apellis Pharmaceuticals, Inc. (APLS)

Report Date: 2025-08-26

Detailed Transactions and Holdings:

• Acquired 61,804 shares of Common Stock (Direct)
  Date: 2025-08-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 61,804.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 92,592 shares of Stock Option (Right to Buy) at $16.2 per share (Derivative)
  Date: 2025-08-26 | Code: A | Expires: 2035-08-26 | equity_swap_involved: 0 | shares_owned_after: 92,592.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: This restricted stock unit was granted on August 26, 2025. The restricted stock unit will vest 25% annually over four years from grant date, subject to her continued service as an officer, or upon later termination of her service.
• F2: This represents a stock option award granted August 26, 2025 that vests over a four-year period. 25% vests one year from grant date and the remaining 75% vests monthly thereafter subject to continued service.